NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financia... (e NPS reported net income of $14.1 mi...)

NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financial Guidance

Date:11/1/2007

NPS reported net income of $14.1 million for the third quarter of 2007 and ended the quarter with $302.2 million in cash and marketable securities. During the third quarter the following financial transactions were executed:

-- NPS granted Nycomed the rights to develop and market GATTEX outside

North America, which generated an up-front payment of $10 million;

-- NPS sold $11 million of Preotact(R) bulk drug supply to Nycomed;

-- The Preotact royalty entitlement was sold to Drug Royalty LP 3 for an

up-front payment of $50 million;

-- $50 million of convertible notes were issued to Visium Asset

Management;

-- $100 million in Sensipar(R) royalty-backed notes were issued;

-- $20.2 million of 3% Convertible Notes were repurchased for $19.5

million.

Subsequent to the close of the third quarter the following transactions were completed:

-- NPS sold its interests in the mGluR research and development program

to partner AstraZeneca for $30 million;

-- $171.2 million of its outstanding 3% Convertible Notes were repurchased

through a cash tender offer for $169.1 million;

-- Nycomed elected to proceed with the GATTEX licensing agreement,

triggering a $25 million additional upfront payment to NPS.

Excluding the net proceeds generated by new business development activities and financing transactions executed in 2007, NPS now expects to have a 2007 cash burn between $70 and $80 million, a change from its earlier guidance of $80 to $90 million. As a result of the reduced cash burn, recent transactions and gains on facilities sales, NPS is revising its previous year end cash balance guidance of $65 to $75 million to a new range of between $130 and $140 million.

NPS projects that its 2008 cash burn will be $35 to 45 million, as indicated in previous guidance. With the reduced cash burn and revised cash balance, NPS should have sufficient cash
'/>"/>

SOURCE NPS Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss

Post Your Comments:

(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader ... international validation of the cutting-edge science behind its ... around the world rediscovered the Cyclin G1 ... cancer pathogenesis and disease progression, and thus a ... the NIH National Cancer Institute investigating the role ...

(Date:12/15/2009)... Dec. 15 Reportlinker.com announces that ... in its catalogue: ,, The ... Forecasts to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, ... "The Future of Orphan Diseases Therapeutics - ...

(Date:12/15/2009)... The Mosaic Company (NYSE: MOS ) ... earnings results and financial tables on Tuesday, January 5, ... York Stock Exchange. Results will be available on ... will host a conference call with presentation slides on ... The call will begin at 11:00 a.m. Eastern Standard ...

(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...

[0] Scientists Rediscover Gene Target for Cancer Therapy [0] Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement [0] Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call [0] Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials

... Educating and advising potential angel investors, or cherubs, on ... was the goal of a seminar at the ... Private Equity and Angel Investing Boot Camp, exposed audience ... and initiatives customized to help burgeoning investors make smart ...

... Wisconsin: "Citizens Arrest! Citizens Arrest!" , ,Before I discuss the ... own state energy source priority statutes, I probably need to explain ... to remember and for those who never had time to enjoy ... automobile mechanic in mythic Mayberry, NC on the Andy Griffith Show, ...

... Wisconsin Entrepreneurs Conference, held at the Hyatt Regency Milwaukee, ... on starting a company, learn how to improve revenue ... state. , ,However, at the conference luncheon on Tuesday, ... industry representatives by the guest speakers: inspiration. During ...

Other Biology Technology:Angel investor boot camp advises and educates cherubs 2 Angel investor boot camp advises and educates cherubs 3 Wisconsin ignores Energy Priority Statutes call for conservation and efficiency 2 Wisconsin ignores Energy Priority Statutes call for conservation and efficiency 3 Celebrating Wisconsins entrepreneurial spirit 2 Celebrating Wisconsins entrepreneurial spirit 3

Angel investor boot camp advises and educates cherubs Wisconsin ignores Energy Priority Statutes call for conservation and efficiency Celebrating Wisconsins entrepreneurial spirit

(Date:12/15/2009)... an agreement with the British Society for Research on ... journal Biogerontology for an initial period of ... of the Biogerontology editorial board and will ... will sponsor the society and provide society members with ... www.springerlink.com . , Biogerontology offers a platform ...

(Date:12/15/2009)... Scientists at VIB and Ghent University in Flanders, Belgium ... septic shock, the major cause of death in intensive ... (NO) gas in mice with septic shock, researchers Anje ... showed much less damage, while their chances of survival ... is generally assumed that nitric oxide is responsible for ...

(Date:12/15/2009)... team of Spanish and American researchers found the fossil remains ... Now they have published, for the first time, the results ... death of the young cetacean, possibly a baleen whale from ... of the partial fossil remains of a whale from the ... sedimentary formation, but it is the first time that the ...

Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2 Story of 4.5 million-year-old whale unveiled in Huelva 2 Story of 4.5 million-year-old whale unveiled in Huelva 3 Canadian based UN coral reef expert honored at world meeting in Australia 8727 1 Canadian based UN coral reef expert honored at world meeting in Australia 8727 2 Study 3A Illegal fishing harming present and future New England groundfish fisheries 8724 1 Study 3A Illegal fishing harming present and future New England groundfish fisheries 8724 2 Biologists devise unifying framework to explain evolutionary puzzles 8721 1 Biologists devise unifying framework to explain evolutionary puzzles 8721 2

[0] Springer signs agreement with British Society of Research on Ageing [0] Septic shock: Nitric oxide beneficial after all [0] Story of 4.5 million-year-old whale unveiled in Huelva

... that, like proverbial birds of a feather, engineered ... together. This tendency, they maintain, should reduce ... the number of nanotechnology-enabled products grows. , Think ... advisor to the Project on Emerging Nanotechnologies at ...

... around the world report in the Oct. 12 issue of ... tiny green alga called Chlamydomonas, with implications for human diseases. ... soil and ponds, has approximately 15,000 genes, and scientists now ... years ago, they knew less than 2 percent. , "It,s ...

... hydrocarbon lakes and seas on Saturn,s moon Titan taken by ... radar image comprised from seven Titan fly-bys over the last ... giant lakes and seas, at least one of them larger ... on Earth. Approximately 60% of Titan,s north polar region, above ...

Other Biology News:Nanoparticle exposures happen, says expert 2 Study involving more than 100 scientists provides new insights on green algae 2 Study involving more than 100 scientists provides new insights on green algae 3 Study involving more than 100 scientists provides new insights on green algae 4 Cassini's new view of land of lakes and seas 2

Nanoparticle exposures happen, says expert Study involving more than 100 scientists provides new insights on green algae Cassini's new view of land of lakes and seas

... Proliferation Marker, prediluted Ki67 antigen is ... expressed by proliferating cells in all phases ... G2 and M phase). It is absent ... useful in establishing the cell growing fraction ...

UBC13 Antibody...

Request Info...

HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....

Biology Products:

Rabbit Anti-Ki67 Polyclonal Antibody, Unconjugated from GeneTex Rabbit Anti-UBC13 Polyclonal Antibody, Unconjugated from ProSci, Inc 10% BSA in TBS from Upstate Mouse Anti-Human HLA II DG+DR+DP Monoclonal Antibody, Unconjugated, Clone IQU9 from Diaclone

NPS Pharmaceuticals Reports Third Quarter 2007 Financial Results, Revises Financia...(e NPS reported net income of $14.1 mi...)